Condition
Blood Transfusion Associated Adverse Reactions
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Recruiting2
Withdrawn1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07536152Phase 4RecruitingPrimary
Antihistamine for Prevention of HTR After Blood Primed CPB
NCT06443515Not ApplicableRecruiting
Respiratory Trends During Blood Transfusions in Newborns.
NCT04388722Not ApplicableWithdrawn
Monitoring Noninvasively for Infusion and Transfusion Optimization
Showing all 3 trials